DEA Schedule CIV
Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097097407
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
MEPROBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA040797On Market Since
6/7/2021
Related Drugs
Same classification
No related drugs found.